Article
Genome-wide association study in chondrocalcinosis reveals ENPP1 as a candidate therapeutic target in calcium pyrophosphate deposition disease.
Annals of the rheumatic diseases - 1 Jun 2025
Takei Riku, Rosenthal Ann, Pascart Tristan, Reynolds Richard J, Neogi Tuhina, Terkeltaub Robert, Tedeschi Sara K, Merriman Tony R
Abstract excerpt
OBJECTIVES: The genetic basis of calcium pyrophosphate deposition (CPPD) disease is unknown. This limits the development of therapeutic strategies. We aimed to analyse a genome-wide association study (GWAS) on a large administrative database to identify new candidate causal genes for CPPD disease. METHODS: We used publicly available GWAS summary statistics for Phecode-defined chondrocalcinosis and crystal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
